Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients
about
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG.Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach.Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.Initial therapy for acute myeloid leukemia in older patients: principles of care.Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia).
P2860
Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clofarabine Plus Low-Dose Cyta ...... herapy in Elderly AML Patients
@ast
Clofarabine Plus Low-Dose Cyta ...... herapy in Elderly AML Patients
@en
type
label
Clofarabine Plus Low-Dose Cyta ...... herapy in Elderly AML Patients
@ast
Clofarabine Plus Low-Dose Cyta ...... herapy in Elderly AML Patients
@en
prefLabel
Clofarabine Plus Low-Dose Cyta ...... herapy in Elderly AML Patients
@ast
Clofarabine Plus Low-Dose Cyta ...... herapy in Elderly AML Patients
@en
P2093
P2860
P50
P1476
Clofarabine Plus Low-Dose Cyta ...... herapy in Elderly AML Patients
@en
P2093
Courtney DiNardo
Guillermo Garcia-Manero
Koichi Takahashi
P2860
P304
163-8.e1-2
P356
10.1016/J.CLML.2015.11.016
P407
P50
P577
2015-11-24T00:00:00Z